Jaguar Health (NASDAQ:JAGX) Stock Passes Below 50-Day Moving Average – Should You Sell?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.98 and traded as low as $0.86. Jaguar Health shares last traded at $0.89, with a volume of 367,642 shares.

Jaguar Health Price Performance

The stock has a fifty day moving average of $0.98 and a 200-day moving average of $1.24. The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65.

Institutional Trading of Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new stake in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent quarter. 12.04% of the stock is currently owned by institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.